Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$1.32 0.00 (0.00%)
As of 01/17/2025

About IMAC Stock (NASDAQ:IMAC)

Key Stats

Today's Range
$1.30
$1.39
50-Day Range
$1.01
$1.41
52-Week Range
$0.75
$1.65
Volume
28,446 shs
Average Volume
708,132 shs
Market Capitalization
$34.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

Mac mini M4 vs iMac M4: Which is the one for you?
Wall St turns to THIS catalyst after Trump’s inauguration
Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $1.27 on January 1st, 2025. Since then, IMAC stock has increased by 3.9% and is now trading at $1.32.
View the best growth stocks for 2025 here
.

IMAC Holdings, Inc. (NASDAQ:IMAC) issued its quarterly earnings data on Thursday, April, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. IMAC had a negative net margin of 75.40% and a negative trailing twelve-month return on equity of 52.17%.

IMAC (IMAC) raised $4 million in an initial public offering (IPO) on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), iBio (IBIO), VBI Vaccines (VBIV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Energy Transfer (ET).

Company Calendar

Last Earnings
4/14/2022
Today
1/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$34.96 million
Optionable
Not Optionable
Beta
-0.88
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners